Fusen Pharmaceutical Company Limited 福森藥業有限公司

Pay for financial year ended 2023-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Cao, Changcheng 曹長城 Ch, Fdr 65 65
2 Cao, Zhiming 曹智銘 CEO 1,620 3,250 127 4,997
3 Chi, Yongsheng 遲永勝 FD 71 7 78
4 Hou, Taisheng 侯太生 ED 74 7 81
5 Lee, Louis Kwok Tung 李國棟 INED 162 162
6 Meng, Qingfen 孟慶芬 ED 62 62
7 Sze, Wing Chun 施永進 INED 162 162
8 To, Kit Wa 杜潔華 INED 162 162
Total 486 1,892 3,250 141 0 5,769

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 495 1,835 275 97 0 2,702 Report
2023-12-31 486 1,892 3,250 141 0 5,769 Report
2022-12-31 462 1,733 342 43 0 2,580 Report
2021-12-31 447 1,791 373 44 0 2,655 Report
2020-12-31 442 1,352 434 31 0 2,259 Report
2019-12-31 477 672 0 51 0 1,200 Report
2018-12-31 231 599 0 30 0 860 Report
Total 3,040 9,874 4,674 437 0 18,025

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top